Literature DB >> 15790449

Lymph node spread in stage III or IV primary peritoneal serous papillary carcinoma.

Gil Dubernard1, Philippe Morice, Annie Rey, Sophie Camatte, Patricia Pautier, Catherine Lhommé, Pierre Duvillard, Damienne Castaigne.   

Abstract

BACKGROUND: The aim of this study was to determine the rates and topography of pelvic and para-aortic nodal involvement in patients with stage III or IV primary peritoneal serous papillary carcinoma (PSPC).
METHODS: Retrospective review of 19 women who underwent a systematic bilateral pelvic and para-aortic lymphadenectomy.
RESULTS: The overall frequency of lymph node involvement was 63% (12/19). Eighteen patients underwent complete resection of peritoneal disease. Only 4 patients underwent this procedure as part of their initial surgery (before chemotherapy). The frequency of pelvic and para-aortic metastases was 58% (11/19) and 58% (11/19), respectively. When para-aortic nodes were involved, the left para-aortic chain above the level of the inferior mesenteric artery was the site most frequently involved (72%). The event-free survival of the 18 patients without macroscopic disease at the end of debulking surgery was significantly correlated with the nodal status. None of the patients with positive nodes developed recurrent disease in abdominal nodes.
CONCLUSIONS: The rate of nodal involvement in patients with PSPC is high. The topography of nodal spread is similar to that of ovarian cancer. Lymphadenectomy has a prognostic value.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15790449     DOI: 10.1016/j.ygyno.2004.12.002

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  6 in total

1.  Recent progress in the diagnosis and treatment of ovarian cancer.

Authors:  Danijela Jelovac; Deborah K Armstrong
Journal:  CA Cancer J Clin       Date:  2011-04-26       Impact factor: 508.702

2.  A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience.

Authors:  Holger Moch; Alwin Krämer; Chantal Pauli; Tilmann Bochtler; Linda Mileshkin; Giulia Baciarello; Ferran Losa; Jeffrey S Ross; George Pentheroudakis; George Zarkavelis; Suayib Yalcin; Mustafa Özgüroğlu; Andreas Beringer; Jeremy Scarato; Mathis Mueller-Ohldach; Marlene Thomas
Journal:  Oncologist       Date:  2021-03-25

3.  Invasive recurrence of an intestinal-type mucinous epithelial neoplasm of low malignant potential: case report and review of the literature.

Authors:  S Cosyns; M Leyder; C Bourgain; P De Sutter
Journal:  Case Rep Oncol       Date:  2011-08-31

4.  Extraovarian Primary Peritoneal Carcinomatosis: A Case Report.

Authors:  Gregory Nicolas; Tony Kfoury; Hassan Fawaz; Mahdi Issa
Journal:  Am J Case Rep       Date:  2017-06-26

5.  Development and Validation of Prognostic Nomogram for Primary Peritoneal Serous Carcinoma Compared With FIGO Staging System: A Population-Based Study.

Authors:  Ming Chen; Zhenzhen Wen; Zhengwei Qi; Min Gao
Journal:  Front Oncol       Date:  2021-08-19       Impact factor: 6.244

6.  Inguinal Lymph Node Metastasis of a Primary Serous Papillary Carcinoma of the Peritoneum One Year after CRS and HIPEC.

Authors:  Shadi Katou; Mathilde Feist; Wieland Raue; Johann Pratschke; Beate Rau; Andreas Brandl
Journal:  Visc Med       Date:  2018-01-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.